|
|
Volumn 335, Issue 14, 1996, Pages 1069-1070
|
|
Esophagitis and alendronate [3]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG WITHDRAWAL;
ESOPHAGITIS;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
CHEMICALLY INDUCED DISORDER;
ESOPHAGUS DISEASE;
FEMALE;
NOTE;
POSTMENOPAUSE OSTEOPOROSIS;
ULCER;
ALENDRONATE;
DIPHOSPHONATES;
ESOPHAGEAL DISEASES;
ESOPHAGITIS;
FEMALE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
ULCER;
|
|
EID: 0029665368
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199610033351416 Document Type: Letter |
|
Times cited : (44)
|
|
References (0)
|
